Back to search

Article

Integrating Tuberculosis and COVID-19 Molecular Testing in Lima, Peru

2022-07-27

Abstract excerpt

Background: Tuberculosis case notifications have plummeted since the COVID-19 pandemic began. Integrated molecular testing could be an opportunity to detect and provide care for both diseases. Many high tuberculosis burden countries have existing GeneXpert networks for tuberculosis testing using Xpert MTB/RIF Ultra (Ultra), and a GeneXpert SARS-CoV-2 assay, Xpert Xpress SARS-CoV-2 (Xpress), is also available. We a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
16cffebf-9b86-513d-9cee-fd9d5cf59f29
DOI
10.2139/ssrn.4174292
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrating Tuberculosis and COVID-19 Molecular Testing in Lima, PeruDOI 10.2139/ssrn.4174292
Select a neighboring publication to make it the new centre.